Zhang Han, Shen Feng, Han Jun, Shen Yi-Nan, Xie Guo-Qiang, Wu Meng-Chao, Yang Tian
Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Hepat Oncol. 2016 Jan;3(1):83-91. doi: 10.2217/hep.15.34. Epub 2015 Nov 30.
Intrahepatic cholangiocarcinoma (ICC) is a rare hepatobiliary malignancy arising from the epithelial cells of the intrahepatic bile ducts. The increased incidence of ICC worldwide may reflect both a true increase and the earlier detection of the disease. Despite the advances in modern surgical care, the curative chance for ICC remained suboptimal: tumor-free margins are hard to achieve due to tumor locations, and technical challenges and recurrence, either local or distant, may hamper the resectability in a large number of patients. Lymph node involvement and vascular invasions are considered negative predictive factors for survival of ICC patients. This review discusses the epidemiology, risk factors and surgical management of ICCs, and mainly focuses on outcomes and factors associated with surgical treatment.
肝内胆管癌(ICC)是一种起源于肝内胆管上皮细胞的罕见肝胆恶性肿瘤。全球范围内ICC发病率的上升可能既反映了实际发病率的增加,也反映了疾病的早期发现。尽管现代外科治疗取得了进展,但ICC的治愈机会仍然不尽人意:由于肿瘤位置的原因,很难实现切缘无肿瘤,而且技术挑战以及局部或远处复发可能会妨碍大量患者的可切除性。淋巴结受累和血管侵犯被认为是ICC患者生存的负面预测因素。本综述讨论了ICC的流行病学、危险因素和外科治疗,主要关注与手术治疗相关的结果和因素。